[<sup>18</sup>F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer.

Neoplasia · 2025 · PMC12159234 · PMID 40424979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The SUV mean metrics indicated a decreasing trend in the treated groups, though the change was not statistically significant ( Fig. 2 e ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

[&lt;sup&gt;18&lt;/sup&gt;F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer.

The sentences

[<sup>18</sup>F]-FLT-PET to evaluate how the sequencing of chemotherapies impacts the efficacy of combination treatment in mouse models of triple-negative breast cancer.